Skip to main content
PLEASE NOTE: For everyone’s safety, Fasken requires anyone on-site at our Canadian and Johannesburg offices to provide proof of full vaccination against COVID-19. This applies to lawyers, staff, clients, service providers and other visitors.
Client Work

Illumina completes acquisition of GenoLogics

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

GenoLogics Life Science Software Inc.

On September 1, 2015, Illumina, Inc. (NASDAQ: ILMN) announced it had completed the acquisition of GenoLogics Life Science Software Inc., a developer of laboratory information management systems for life sciences organizations.
 
Fasken’s Keith Spencer (technology) and Iain Mant (M&A) advised GenoLogics on the transaction.

Team

    Subscribe

    Receive email updates from our team

    Subscribe